公司资料
IGC Pharma, Inc. 股价、新闻与催化剂
- 股票代码:
- IGC
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.28 USD (-5.98%)
收盘价
最后更新: 2026年8月17日
29M USD
市值
股价为何变动
As of Aug 17, 2026, IGC closed down 5.98% at $0.2800. No new same-company headline was identified in the current news window.
公司概览
业务概览
IGC Pharma is a biopharmaceutical company exploring cannabinoid-based and other therapeutic programs, including neuropsychiatric and metabolic concepts. Its identity has been tied to a broad but still early-stage development story.
所在地与行业分类
IGC Pharma is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotech with a neuropsychiatry and cannabinoid angle.
商业模式特征
The company depends on early development work, regulatory pathfinding, and capital efficiency. Investors typically watch program updates, preclinical or early clinical signals, and whether the company can sharpen its focus.
生物医药行业定位
IGC occupies a speculative small-cap biotechnology niche. It is more of an early-stage concept story than a mature clinical platform.
未来催化剂
- IGC Pharma’s catalysts are its cannabis-derived and neuro-related programs, plus any operating update that clarifies commercial progress. The market will care about whether the company can turn the platform into a real business.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。